{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T11:44:30Z","timestamp":1774611870776,"version":"3.50.1"},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.jcrc.2020.05.017","type":"journal-article","created":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T04:17:27Z","timestamp":1590725847000},"page":"32-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Clinically significant anticardiolipin antibodies associated with COVID-19"],"prefix":"10.1016","volume":"59","author":[{"given":"Sami","family":"Hossri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Shadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaid","family":"Hamarsha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rick","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dany","family":"El-Sayegh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"0","key":"10.1016\/j.jcrc.2020.05.017_bb0005","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"0","author":"Klok","year":"2020","journal-title":"Thromb Res"},{"issue":"10223","key":"10.1016\/j.jcrc.2020.05.017_bb0010","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jcrc.2020.05.017_bb0015","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jcrc.2020.05.017_bb0020","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1182\/asheducation-2013.1.675","article-title":"Antiphospholipid syndrome","volume":"2013","author":"Lim","year":"2013","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"17","key":"10.1016\/j.jcrc.2020.05.017_bb0025","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMc2007575","article-title":"Coagulopathy and antiphospholipid antibodies in patients with Covid-19","volume":"382","author":"Zhang","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jcrc.2020.05.017_bb0030","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/ard.62.5.388","article-title":"Antiphospholipid antibodies and infections","volume":"62","author":"Asherson","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jcrc.2020.05.017_bb0035","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1182\/asheducation-2003.1.497","article-title":"Platelet-endothelial interactions: sepsis, HIT, and antiphospholipid syndrome","author":"Warkentin","year":"2003","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jcrc.2020.05.017_bb0040","article-title":"Lupus anticoagulant is frequent in patients with Covid-19","author":"Harzallah","year":"2020","journal-title":"J Thromb Haemost"}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088394412030575X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088394412030575X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:43:11Z","timestamp":1760125391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088394412030575X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":8,"alternative-id":["S088394412030575X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2020.05.017","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinically significant anticardiolipin antibodies associated with COVID-19","name":"articletitle","label":"Article Title"},{"value":"Journal of Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrc.2020.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}